KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EPS (Basic) (2016 - 2025)

Thermo Fisher Scientific's EPS (Basic) history spans 17 years, with the latest figure at $5.22 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 8.98% year-over-year to $5.22, compared with a TTM value of $17.77 through Dec 2025, up 7.24%, and an annual FY2025 reading of $17.77, up 7.18% over the prior year.
  • EPS (Basic) for Q4 2025 was $5.22 at Thermo Fisher Scientific, up from $4.28 in the prior quarter.
  • The five-year high for EPS (Basic) was $5.93 in Q2 2021, with the low at $3.34 in Q2 2023.
  • Average EPS (Basic) over 5 years is $4.36, with a median of $4.26 recorded in 2022.
  • Year-over-year, EPS (Basic) soared 197.99% in 2021 and then crashed 40.99% in 2023.
  • Tracing TMO's EPS (Basic) over 5 years: stood at $4.21 in 2021, then decreased by 4.28% to $4.03 in 2022, then grew by 4.47% to $4.21 in 2023, then increased by 13.78% to $4.79 in 2024, then increased by 8.98% to $5.22 in 2025.
  • Per Business Quant, the three most recent readings for TMO's EPS (Basic) are $5.22 (Q4 2025), $4.28 (Q3 2025), and $4.28 (Q2 2025).